Clearstead Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,741
| Closed | -$583K | – | 2447 |
|
|
2025
Q4 | $583K | Buy |
5,741
+2,269
| +65% | +$182K | 0.01% | 608 |
|
|
2025
Q3 | $190K | Buy |
3,472
+365
| +12% | +$18.2K | ﹤0.01% | 894 |
|
|
2025
Q2 | $165K | Buy |
3,107
+428
| +16% | +$21.7K | ﹤0.01% | 930 |
|
|
2025
Q1 | $116K | Buy |
2,679
+254
| +10% | +$12.9K | ﹤0.01% | 953 |
|
|
2024
Q4 | $136K | Hold |
2,425
| – | – | ﹤0.01% | 947 |
|
|
2024
Q3 | $165K | Sell |
2,425
-238
| -9% | -$13.4K | ﹤0.01% | 914 |
|
|
2024
Q2 | $113K | Buy |
2,663
+238
| +10% | +$13.1K | ﹤0.01% | 972 |
|
|
2024
Q1 | $135K | Hold |
2,425
| – | – | 0.01% | 540 |
|
|
2023
Q4 | $179K | Sell |
2,425
-2,425
| -50% | -$159K | 0.01% | 470 |
|
|
2023
Q3 | $331K | Buy |
4,850
+2,425
| +100% | +$206K | 0.01% | 466 |
|
|
2023
Q2 | $228K | Hold |
2,425
| – | – | 0.01% | 412 |
|
|
2023
Q1 | $164K | Hold |
2,425
| – | – | 0.01% | 420 |
|
|
2022
Q4 | $120K | Hold |
2,425
| – | – | 0.01% | 466 |
|
|
2022
Q3 | $79K | Hold |
2,425
| – | – | 0.01% | 517 |
|
|
2022
Q2 | $96K | Hold |
2,425
| – | – | 0.01% | 508 |
|
|
2022
Q1 | $170K | Hold |
2,425
| – | – | 0.01% | 432 |
|
|
2021
Q4 | $189K | Hold |
2,425
| – | – | 0.01% | 403 |
|
|
2021
Q3 | $231K | Hold |
2,425
| – | – | 0.02% | 346 |
|
|
2021
Q2 | $301K | Hold |
2,425
| – | – | 0.02% | 293 |
|
|
2021
Q1 | $320K | Hold |
2,425
| – | – | 0.03% | 272 |
|
|
2020
Q4 | $321K | Hold |
2,425
| – | – | 0.03% | 255 |
|
|
2020
Q3 | $247K | Hold |
2,425
| – | – | 0.03% | 258 |
|
|
2020
Q2 | $211K | Hold |
2,425
| – | – | 0.02% | 261 |
|
|
2020
Q1 | $141K | Sell |
2,425
-19
| -0.8% | -$1.54K | 0.02% | 282 |
|
|
2019
Q4 | $226K | Buy |
2,444
+19
| +0.8% | +$1.67K | 0.03% | 262 |
|
|
2019
Q3 | $219K | Hold |
2,425
| – | – | 0.03% | 248 |
|
|
2019
Q2 | $286K | Hold |
2,425
| – | – | 0.04% | 225 |
|
|
2019
Q1 | $210K | Buy |
+2,425
| New | +$206K | 0.03% | 249 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Clearstead Advisors's EXAS Position: Q1 2026 in Review
Clearstead Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,741 shares — an estimated $583K sold.
Clearstead Advisors first reported a position in EXAS in Q1 2019 and held it in 28 quarters. The position peaked at $583K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Clearstead Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Clearstead Advisors sold 5,741 Exact Sciences shares in Q1 2026, an estimated $583K.
- Clearstead Advisors first reported a position in Exact Sciences in Q1 2019 and held it in 28 quarters.
- Clearstead Advisors's Exact Sciences position peaked at $583K in Q4 2025.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.